1/11
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Describe the pathophysiology of allergic rhinitis, including the immunological mechanisms involved in the allergic response. How do these mechanisms contribute to the symptoms experienced by patients with allergic rhinitis?
Discuss the role of allergen avoidance strategies in the management of allergic rhinitis. Provide examples of common allergens and practical measures that patients can take to minimize their exposure to these allergens in their daily lives.
Compare and contract the pharmacological treatment options available for allergic rhinitis, including first-generation and second-generation antihistamines, intranasal corticosteroids, leukotriene receptor antagonists, and nasal decongestants. Discuss the efficacy, safety profiles, and potential side effects of each class of medications.
Explain the concept of immunotherapy as a treatment option for allergic rhinitis. How does immunotherapy work to desensitize the immune system to specific allergens, and what are the different forms of immunotherapy available (e.g., subcutaneous immunotherapy, sublingual immunotherapy)? Discuss the indications, efficacy, and safety considerations associated with immunotherapy in allergic rhinitis management.
Outline a comprehensive patient counseling plan for a newly diagnosed patient with allergic rhinitis. Include key points to cover regarding medication adherence, proper administration techniques for intranasal medications, potential side effects to watch out for, and timing of administration.
Allergic reactions typically occur in two distinct phases: the immediate hypersensitivity reaction and the late-phase reaction. Describe each phase using the following:
Mast cell degranulation
Histamine
Acetylcholine
Eosinophils
Leukotrienes
Mast cell degranulation
Histamine
Acetylcholine
Eosinophils
Leukotrienes
List three major functions of histamine using the following:
Bronchial smooth muscle
Vascular smooth muscle
Nitric oxide
Capillaries
Bronchial smooth muscle
Vascular smooth muscle
Nitric oxide
Capillaries
Diphenhydramine also possesses a non-selective antagonist of muscarinic acetylcholine receptors (mAChRs). Describe the beneficial effect in the management of allergic rhinitis through its anticholinergic properties. Use: “Drying effect”
List the mechanism of action of nasal steroids in allergic rhinitis using the following:
Inflammation
Mast cell
Late-phase reaction
Illustrate the pharmacophore of 1st gen antihistamines.
Give a reason from the structure why 2nd gen antihistamines do not cause sedation.
Discuss the difference between 1st gen and 2nd gen antihistamines.
For inhalation steroids, illustrate the pharmacophore required for activity, and highlight the chemical structures needed to increase the anti-inflammatory capabilities with example from drugs in the market.